Copyright
©The Author(s) 2019.
World J Clin Oncol. Mar 24, 2019; 10(3): 136-148
Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.136
Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.136
Table 2 Genotypes in patients and controls of fibroblast growth factor receptor 4 and calculated probability of gene distribution in second rows n (%)
| Fibroblast growth factor receptor 4 genotypes | Cancer cases (n = 284) | Controls (n = 123) |
| Gly/Gly | 188 (66.2) | 55 (45) |
| 0.65 | 0.47 | |
| Gly/Arg | 84 (29.6) | 60 (49) |
| 0.3 | 0.42 | |
| Arg/Arg | 12 (4.2) | 8 (6) |
| 0.03 | 0.09 |
- Citation: Wimmer E, Ihrler S, Gires O, Streit S, Issing W, Bergmann C. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas. World J Clin Oncol 2019; 10(3): 136-148
- URL: https://www.wjgnet.com/2218-4333/full/v10/i3/136.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i3.136